Project Grant HT94252410069
Award Date
3/1/24
Completion Date
2/28/26
Dollars Obligated
$356K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
The Children's Hospital of Philadelphia (CHOP) has been awarded a $1,773,720.00 Project Grant under the Military Medical Research and Development program (CFDA 12.420) by the Defense Health Agency. This award, with a period of performance from July 1, 2024 to June 30, 2028, will support research to elucidate the cardiomyopathy associated with the mitochondrial disorder Friedreich's ataxia. CHOP, a leading pediatric hospital and research facility, will leverage its expertise in areas like genetic...
The Children's Hospital of Philadelphia (CHOP) was awarded a $801,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports research targeting "MARROW NICHE DYSREGULATION DURING STEM CELL TRANSPLANT FOR BONE MARROW FAILURE ASSOCIATED WITH MONOSOMY 7 MYELODYSPLASTIC SYNDROMES." This multi-year research project, running from September 1, 2023 to August 31, 2026, aims to investigate medical solutions...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $356,000.00 to The Children's Hospital of Philadelphia (CHOP) to study the impact on ketosis phenotype. The performance period for this award is from Sep 1, 2024 to Aug 31, 2026. As a leading pediatric research institution, CHOP leverages its expertise in areas such as genetic disorders and neurological conditions to contribute to...
The Children's Hospital of Philadelphia was awarded a $23.7 million Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program. The grant will support the development and clinical validation of noninvasive diagnostics for mitochondrial disease from 2022 through 2026. Through this funding, the awardee will work to transform healthcare for service members and the public by investigating medical solutions for the...
The Children's Hospital of Philadelphia will receive $3.52 million under a four-year Project Grant from the Department of the Army Medical Command. The grant will support the ANT1 Gene Therapy for the Treatment of Mitochondrial Disease project from July 2022 through June 2026. The project aims to develop a gene therapy for mitochondrial diseases, which are genetic disorders caused by dysfunctional mitochondria. The Children's Hospital of Philadelphia Research Institute will investigate using the...
The Children's Hospital of Philadelphia will receive $3.52 million under a four-year Project Grant from the Department of the Army Medical Command. The grant will support the ANT1 Gene Therapy for the Treatment of Mitochondrial Disease project from July 2022 through June 2026. The project aims to develop a gene therapy for mitochondrial diseases, which are genetic disorders caused by dysfunctional mitochondria. The Children's Hospital of Philadelphia Research Institute will investigate using...
The U.S. Department of the Army Medical Command awarded a $326,712 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program to The Children's Hospital of Philadelphia (CHOP) Research Institute. The grant, which runs from September 1, 2025 to August 31, 2027, will fund a structured lipid nutrition intervention study focused on symptom management and quality of life improvements. As a leading pediatric healthcare provider and research institution,...
The U.S. Defense Health Agency awarded a $1,751,725 Project Grant to The Children's Hospital of Philadelphia (CHOP) to conduct research on "VALIDATION OF NOVEL DRIVERS OF JUVENILE POLYPOSIS SYNDROME" from September 1, 2023 to August 31, 2027. CHOP, a pediatric hospital and research center, will use this funding from the Military Medical Research and Development program (CFDA 12.420) to transform health care for Service Members and the American public through innovative and impactful...
The federal Project Grant award for $676,117.00 was provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research at The Children's Hospital of Philadelphia (CHOP) to investigate "EXPANDED GAA-GGA CHIMERIC REPEATS IN FRIEDREICH ATAXIA". The research aims to transform healthcare for military service members and the broader public by advancing the understanding and...
The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $1,273,300 Project Grant to The Children's Hospital of Philadelphia (CHOP) to conduct research on identifying and reversing functional cerebellar circuit dysfunctions in a mouse model of Friedreich's ataxia. The grant, with a performance period from September 1, 2024 to August 31, 2028, will support CHOP's pioneering research efforts to advance understanding and treatment of this...